Neurotrophic factors and the pathophysiology of schizophrenic psychoses

被引:117
作者
Durany, N
Thome, J
机构
[1] Univ Int Catalunya, Fac Hlth Sci, Barcelona 08190, Spain
[2] Heidelberg Univ, Cent Inst Mental Hlth, Heidelberg, Germany
关键词
antipsychotic drugs; BDNF; CNTF; maldevelopment; neurogenesis; neuroleptics; NGF; NT-3; NTF;
D O I
10.1016/j.eurpsy.2004.06.020
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
The aim of this review is to summarize the present state of findings on altered neurotrophic factor levels in schizophrenic psychoses, on variations in genes coding for neurotrophic factors, and on the effect of antipsychotic drugs on the expression level of neurotrophic factors. This is a conceptual paper that aims to establish the link between the neuromaldevelopment theory of schizophrenia and neurotrophic factors. An extensive literature review has been done using the Pub Med database, a service of the National Library of Medicine, which includes over 14 million citations for biomedical articles back to the 1950s. The majority of studies discussed in this review support the notion of alterations of neurotrophic factors at the protein and gene level, respectively, and support the hypothesis that these alterations could, at least partially, explain some of the morphological, cytoarchitectural and neurobiochemical abnormalities found in the brain of schizophrenic patients. However, the results are not always conclusive and the clinical significance of these alterations is not fully understood. It is, thus, important to further neurotrophic factor research in order to better understand the etiopathogenesis of schizophrenic psychoses and, thus, potentially develop new treatment strategies urgently needed for patients suffering from these devastating disorders. (C) 2004 Published by Elsevier SAS.
引用
收藏
页码:326 / 337
页数:12
相关论文
共 161 条
[1]
Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo [J].
Agerman, K ;
Ernfors, P .
NEUROREPORT, 2003, 14 (17) :2183-2187
[2]
AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169
[3]
BRAIN-DERIVED NEUROTROPHIC FACTOR INCREASES SURVIVAL AND DIFFERENTIATED FUNCTIONS OF RAT SEPTAL CHOLINERGIC NEURONS IN CULTURE [J].
ALDERSON, RF ;
ALTERMAN, AL ;
BARDE, YA ;
LINDSAY, RM .
NEURON, 1990, 5 (03) :297-306
[4]
Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders [J].
Aloe, L ;
Iannitelli, A ;
Angelucci, F ;
Bersani, G ;
Fiore, M .
BEHAVIOURAL PHARMACOLOGY, 2000, 11 (3-4) :235-242
[5]
Anterograde transport of brain-derived neurotrophic factor and its role in the brain [J].
Altar, CA ;
Cai, N ;
Bliven, T ;
Juhasz, M ;
Conner, JM ;
Acheson, AL ;
Lindsay, RM ;
Wiegand, SJ .
NATURE, 1997, 389 (6653) :856-860
[6]
ALTAR CA, 1993, J NEUROSCI, V13, P733
[7]
Downregulation of brain-derived neurotrophic factor mRNA in adult rat brain after acute administration of methylmercury [J].
Andersson, H ;
Lindqvist, E ;
Olson, L .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1997, 31 (03) :225-233
[8]
Angelucci F, 2000, J NEUROSCI RES, V60, P783, DOI 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO
[9]
2-M
[10]
Apfel SC, 1999, BRAIN PATHOL, V9, P393